MIT-Takeda Program heads into fourth year with crop of 10 new projects
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
A new educational program for scientists working on substance use disorder
MIT Open Learning team awarded NIH grant to provide training in biomedical product development, entrepreneurship, and innovation.
Startups led by MIT mechanical engineers offer health care solutions
Companies founded by MechE faculty and alumni solve a variety of health care challenges, from better drug delivery to robotic surgery.
2022-23 Takeda Fellows: Leveraging AI to positively impact human health
New fellows are working on health records, robot control, pandemic preparedness, brain injuries, and more.
Professor Emeritus Richard Wurtman, influential figure in translational research, dies at 86
Longtime MIT professor of neuroscience led research behind 200 patents, laying the groundwork for numerous medical products.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
The economics of missed opportunities
Danielle Li takes a close look at scientific practices and organizational decisions — and provides data about improving them.
Artificial intelligence model can detect Parkinson’s from breathing patterns
An MIT-developed device with the appearance of a Wi-Fi router uses a neural network to discern the presence and severity of one of the fastest-growing neurological diseases in the world.
Artificial intelligence model finds potential drug molecules a thousand times faster
A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
Can artificial intelligence overcome the challenges of the health care system?
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
3 Questions: Daniel Anderson on the progress of mRNA vaccines
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Q&A: Chris Rackauckas on the equations at the heart of practically everything
Have a question about numerical differential equations? Odds are this CSAIL research affiliate has already addressed it.
A smarter way to develop new drugs
A new artificial intelligence technique only proposes candidate molecules that can actually be produced in a lab.
An “oracle” for predicting the evolution of gene regulation
Researchers create a mathematical framework to examine the genome and detect signatures of natural selection, deciphering the evolutionary past and future of non-coding DNA.
SMART researchers discover unique lysin capable of killing multidrug-resistant bacteria
Novel lysin Abp013 has shown promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae.